project id: TCGA-BRCA; case submitter id: TCGA-EW-A1P8; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.0; rna integrity number: 7.8; spectrophotometer method: UV Spec; age at index: 58; days to birth: -21501; days to death: 239; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1952; year of death: 2010; age at diagnosis: 21501; ajcc pathologic m: M0; ajcc pathologic n: N3b; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 224; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-EW-A1P8-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;